Hepatic fibrosis is the buildup of abnormal scar tissue in the liver that occurs when the organ tries to heal itself after repeated or continuous injury. This scarring process happens gradually and can affect how well your liver works, though early stages may be reversible if the underlying cause is addressed promptly.

Understanding Hepatic Fibrosis

Hepatic fibrosis represents the liver’s response to ongoing damage. When your liver experiences a single episode of injury, even a severe one like acute hepatitis, it typically repairs itself successfully by creating new liver cells and connecting them to the existing framework of connective tissue. However, when injury happens repeatedly or continuously, the repair process goes wrong, and instead of healthy liver tissue, scar tissue forms^[1].

This scar tissue, unlike normal liver cells, cannot perform any of the liver’s important functions. As more scar tissue accumulates, it begins to distort the liver’s internal structure and interfere with blood flow both to and within the liver. This creates a harmful cycle where reduced blood supply causes more liver cells to die, which in turn leads to even more scar tissue formation^[1].

Cirrhosis is the term used when fibrosis becomes severe and widespread, destroying the liver’s internal structure and significantly impairing its ability to regenerate and function properly. At this advanced stage, the scarring forms bands throughout the liver^[1].

Epidemiology

Hepatic fibrosis accompanies the progression of most types of chronic liver diseases, regardless of their underlying cause. In industrialized countries, the most common causes of liver fibrosis include chronic hepatitis C virus infection, excessive alcohol consumption, and metabolic dysfunction–associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis^[3].

In the United States specifically, chronic excessive alcohol use, viral hepatitis C, and MASH are the leading causes of fibrosis. Metabolic dysfunction–associated steatotic liver disease, which often leads to MASH and subsequent fibrosis, has become increasingly common in recent years. This increase is linked to rising rates of excess body weight, diabetes or prediabetes, and high levels of fats and cholesterol in the blood—a combination often referred to as metabolic syndrome^[1].

Worldwide, viral hepatitis B is a common cause of liver fibrosis. The condition affects people across all demographics, though certain risk factors make some populations more vulnerable than others^[1].

Causes of Hepatic Fibrosis

Hepatic fibrosis develops when the liver experiences chronic or repeated injury. Various disorders, medications, and substances can damage the liver in this way. The injury triggers an activation of specialized cells in the liver called hepatic stellate cells, also known as Ito cells. These cells normally store fat, but when activated, they transform into cells that produce excessive amounts of abnormal scar tissue material, including collagen and other proteins^[5].

Chronic hepatitis C infection causes ongoing inflammation and damage to liver cells. The virus persists in the body, continuously triggering the immune response and repair mechanisms that lead to fibrosis over time^[3].

Chronic excessive alcohol consumption damages liver cells directly through toxic effects. The liver works hard to process alcohol, and repeated exposure overwhelms its capacity, leading to cell death and the subsequent scarring response^[1].

Metabolic dysfunction–associated steatohepatitis occurs when fat accumulates in the liver along with inflammation. This combination of fat buildup, inflammation, and cell death triggers the fibrotic process. People with excess body weight, diabetes, prediabetes, or abnormal cholesterol levels are particularly susceptible^[1].

Certain hereditary metabolic disorders can cause fibrosis by affecting how the body breaks down and processes foods. When foods are not metabolized normally, substances can accumulate in the liver and cause damage. Examples include alpha-1 antitrypsin deficiency, hemochromatosis (iron overload), and Wilson disease (copper storage disease)^[1].

Autoimmune disorders, where the body attacks its own tissues, can target the liver. Conditions like autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis cause ongoing inflammation. In the latter two conditions, bile ducts become inflamed, scarred, and blocked, which accelerates fibrosis development^[1].

Blockages in the bile ducts, whether from gallstones or scarring from previous liver surgery, can cause fibrosis to develop more rapidly. When bile cannot flow properly, it backs up in the liver and causes damage^[5].

Risk Factors

Several factors increase the risk of developing hepatic fibrosis. Understanding these risk factors can help people take preventive measures and seek earlier treatment.

People who consume alcohol excessively over long periods face significantly elevated risk. The liver must process all consumed alcohol, and chronic overuse leads to repeated cellular damage and inflammation that triggers fibrosis^[1].

Individuals with chronic viral hepatitis B or C infections are at high risk because these viruses cause ongoing liver inflammation. The persistent infection creates continuous injury that the liver attempts to repair, leading to progressive scarring over time^[3].

People with excess body weight, diabetes, prediabetes, or abnormal cholesterol and lipid levels face increased risk for developing metabolic dysfunction–associated steatotic liver disease, which can progress to MASH and fibrosis. This combination of risk factors, known as metabolic syndrome, has become increasingly prevalent^[1].

Those with certain hereditary metabolic disorders, such as hemochromatosis, Wilson disease, or alpha-1 antitrypsin deficiency, have inherited conditions that cause substances to accumulate in the liver, leading to progressive damage and fibrosis^[1].

People taking certain medications over long periods may be at risk. Some medications, including methotrexate, amiodarone, and others, can cause liver damage when used chronically^[5].

Individuals with heart failure or blood clotting disorders affecting liver blood vessels face increased risk because these conditions reduce blood flow to the liver, causing cell death and subsequent scarring. Conditions like Budd-Chiari syndrome (blockage of blood flow out of the liver) or portal vein thrombosis (blood clot blocking the main vein to the liver) create this problem^[1].

Symptoms

One of the challenging aspects of hepatic fibrosis is that it typically causes no symptoms on its own, especially in the early stages. Many people with liver fibrosis do not realize they have liver disease because symptoms are often absent or extremely vague^[1].

When symptoms do appear, they are usually mild and nonspecific. People might experience general fatigue or mild discomfort in the upper right area of the abdomen where the liver is located. These symptoms can easily be mistaken for other common health issues^[9].

As fibrosis progresses and more extensive scarring develops, symptoms may become more noticeable. However, even at moderate stages, many individuals still experience few or no obvious signs that something is wrong with their liver^[1].

When fibrosis advances to cirrhosis, more significant symptoms may develop. These can include loss of appetite and unintended weight loss, general weakness, nausea, and yellowing of the skin and eyes, a condition known as jaundice. Fluid may build up in the legs and abdomen, causing swelling. Some people experience confusion or difficulty concentrating as liver function declines^[9].

Severe scarring can lead to increased blood pressure in the portal vein, the large blood vessel that carries blood from the intestine to the liver. This condition, called portal hypertension, can cause serious complications as blood is forced to find alternate routes around the scarred liver^[1].

Prevention

Preventing hepatic fibrosis involves addressing the risk factors and underlying conditions that cause chronic liver injury. Many cases of fibrosis can be prevented through lifestyle choices and appropriate medical care.

Avoiding excessive alcohol consumption is one of the most important preventive measures. For people who struggle with alcohol use, seeking help from addiction specialists can be crucial. Even individuals who have misused alcohol for years can benefit from cessation, as the liver has remarkable healing capacity when the damaging agent is removed^[18].

Maintaining a healthy weight through balanced diet and regular exercise helps prevent metabolic dysfunction–associated steatotic liver disease and MASH. Eating a diet rich in fruits, vegetables, whole grains, and lean proteins while limiting processed foods, saturated fats, and added sugars supports liver health. Regular physical activity helps control weight, improve insulin sensitivity, and reduce fat accumulation in the liver^[18].

Managing existing health conditions like diabetes, high cholesterol, and high blood pressure through medication and lifestyle changes reduces the risk of liver damage. Following your doctor’s treatment recommendations and attending regular check-ups helps optimize care and prevents complications^[18].

Vaccination against hepatitis B prevents infection with this virus. While no vaccine currently exists for hepatitis C, avoiding behaviors that spread the virus, such as sharing needles or having unprotected sexual contact with infected individuals, reduces transmission risk^[18].

Using medications responsibly and only when necessary helps protect the liver. Taking medications exactly as prescribed and avoiding unnecessary drugs reduces the burden on your liver. Certain over-the-counter medications, particularly when used in excess or combined with alcohol, can damage the liver^[18].

Regular screening for liver disease is important for people at high risk. Blood tests can detect early signs of liver problems before symptoms appear, allowing for earlier intervention. People of Asian and Pacific Islander descent who were not born in the United States, for example, should get screened for hepatitis B regularly^[18].

Pathophysiology

The development of hepatic fibrosis involves complex biological processes at the cellular and molecular level. Understanding these mechanisms helps explain how chronic liver injury leads to progressive scarring.

When the liver experiences repeated or continuous injury, specialized cells called hepatic stellate cells become activated. These cells, which normally store vitamin A and fat, undergo a transformation into cells called myofibroblasts. These activated cells proliferate and begin producing excessive amounts of extracellular matrix proteins, particularly collagen and other structural proteins that form scar tissue^[5].

During this activation process, other cells in the liver also become involved. Kupffer cells, which are resident immune cells in the liver, along with injured liver cells, platelets, and white blood cells, gather at sites of damage. These cells release substances called reactive oxygen species and inflammatory mediators. These chemical signals include platelet-derived growth factor, transforming growth factors, and connective tissue growth factor, all of which stimulate stellate cells to produce more scar tissue^[5].

The extracellular matrix produced during fibrosis is abnormal in both quantity and composition compared to normal liver tissue. Normally, the liver maintains a careful balance between producing and breaking down extracellular matrix. In fibrosis, this balance is disrupted, with production far exceeding degradation. The result is progressive accumulation of scar tissue^[5].

The activated myofibroblasts also respond to a substance called endothelin-1, which causes them to contract. This contraction increases resistance to blood flow in the portal vein and makes the abnormal matrix denser and more compact. As scar tissue bands form and connect different parts of the liver, they further distort the organ’s architecture^[5].

The accumulating scar tissue interferes with blood flow through the liver’s intricate network of small blood vessels. This reduced blood supply means less oxygen and nutrients reach healthy liver cells. Without adequate blood supply, these cells die, and their death triggers even more scar tissue formation, creating a vicious cycle^[1].

As fibrosis progresses, it distorts the liver’s normal architecture. Regenerating liver cells attempt to form new tissue, but in the presence of extensive scarring, they form abnormal nodules surrounded by fibrous bands. This disorganized structure characterizes cirrhosis, where the liver can no longer maintain its normal functions effectively^[3].

Fibrosis can develop more rapidly under certain conditions. Mechanical blockage of the bile ducts, for example, accelerates the scarring process significantly. When bile cannot drain properly from the liver, the backup causes additional injury and inflammation that speeds fibrosis development^[1].

The body’s immune system plays a complex role in fibrosis development. In autoimmune liver diseases, the immune system mistakenly attacks liver cells, creating chronic inflammation. In viral hepatitis, the immune response to the virus causes ongoing damage. Even in metabolic liver disease, inflammatory processes contribute to cell injury and fibrosis progression^[10].